MIRA Pharmaceuticals (MIRA)

• Market cap: $45.4M
• 1 day: -6.9%
• 5 days: 11.33%
• 1 month: 6.93%
• 3 months: -16.28%
• 6 months: -27.03%
• Year to date: -27.52%
• 1 year: -19.4%
• 5 years: -85.44%
• 10 years: -85.44%
• Sector: Healthcare
• Industry: Drug Manufacturers - General

About: Mira Pharmaceuticals Inc is a clinical-stage pharmaceutical development company focused on developing novel oral small-molecule therapeutics for neurologic, neuropsychiatric, metabolic, and inflammatory disorders. The company's pipeline includes three product candidates: Ketamir-2, MIRA-55, and SKNY-1, three drug candidates designed to address unmet medical needs across neuropathic and inflammatory pain, central nervous system disorders, and metabolic and behavioral conditions. The company operates as a single operating and reportable segment.

Employees: 2